Schonfeld Strategic Advisors »

4d Molecular Therapeutics In shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 179k 8.69
2024-06-30 $300k 14k 20.99
2022-09-30 $89k 11k 8.02
2022-06-30 $205k 29k 7.00

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In